Graf Akcie APVO (Aptevo Therapeutics Inc). Diskuze k akciím APVO. Aktuální informace APVO.

Základní informace o společnosti Aptevo Therapeutics Inc (Akcie APVO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 66.74M
Hodnota podniku (EV) N/A
Tržby 9.367M
EBITDA N/A
Zisk -29.03
Růst v tržbách Q/Q 557.51 %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 0.00
Forward P/E N/A
EV/Sales 2.95
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 7.13
P/FCF N/A
Price/Book 4.02
Účetní hodnota na akcii 3.76
Hotovost na akcii 9.64
FCF vůči ceně -40.06 %
Počet zaměstnanců 58
Tržba na zaměstnance 161.500k
Profit margin -411.93 %
Operating margin -274.10 %
Gross margin 100.00 %
EBIT margin -309.94 %
EBITDA margin -368.02 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -16.67 %
EPS - Očekávaný růst příští rok -30.00 %
Return on assets -50.23 %
Return on equity -268.93 %
ROIC -33.19 %
ROCE -71.49 %
Dluhy/Equity 2.23
Čistý dluh/EBITDA 0.18
Current ratio 2.13
Quick Ratio 2.13
Volatilita 6.51
Beta 2.65
RSI 43.56
Cílová cena analytiků 66
Známka akcie (dle analytiků) N/A
Insider ownership 5.82 %
Institutional ownership 67.31 %
Počet akcií 4.894M
Procento shortovaných akcií 2.22 %
Short ratio 1.04 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2016
Země United States

Finanční výsledky akcie APVO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$32.424$23.067$14.658$9.985$33.601$45.631-
Cost Of Goods Sold$19.927$11.214$5.01$12.467$16.933$16.254-
Gross Profit$12.497$11.853$9.648$-2.482$16.668$29.377-
Research And Development Expenses$29.757$35.385$29.021$29.12$34.726$46.589-
SG&A Expenses$25.336$28.133$34.576$36.158$43.042$34.28-
Other Operating Income Or Expenses---$-71.013---
Operating Expenses$75.02$74.732$68.607$148.758$94.701$97.123-
Operating Income$-42.596$-51.665$-53.949$-138.773$-61.1$-51.492-
Total Non-Operating Income/Expense$-2.102$-2.024$-1.944$-0.81$-0.237$-0.222-
Pre-Tax Income$-44.698$-53.689$-55.893$-139.583$-61.337$-51.714-
Income Taxes--$-23.301$-19.692$-2.02$-0.599-
Income After Taxes$-44.698$-53.689$-32.592$-119.891$-59.317$-51.115-
Other Income-------
Income From Continuous Operations$-44.698$-53.689$-32.592$-119.891$-59.317$-51.115-
Income From Discontinued Operations$4.25-$39.565$7.476---
Net Income$-40.448$-53.689$6.973$-112.415$-59.317$-51.115-
EBITDA$-40.361$-49.275$-50.822$-135.411$-58.193$-49.471$0.666
EBIT$-42.596$-51.665$-53.949$-138.773$-61.1$-51.492-
Basic Shares Outstanding32211--
Shares Outstanding32211--
Basic EPS$-13.87$-33.47$4.62$-77.73$-41.04--
EPS - Earnings Per Share$-13.87$-33.47$4.62$-77.73$-41.04--
# 2020 2019 2018 2017 2016 2015
Current Ratio0.78442.76485.13693.6541.76172.0948
Long-term Debt / Capital-0.3880.16090.2666--
Debt/Equity Ratio1.67730.6340.23240.3635--
Gross Margin38.542451.385165.8207-24.857349.605764.3795
Operating Margin-131.3718-223.978-368.0515-1389.815-181.8398-112.8443
EBIT Margin-131.3718-223.978-368.0515-1389.815-181.8398-112.8443
EBITDA Margin-124.4788-213.6168-346.7185-1356.144-173.1883-108.4153
Pre-Tax Profit Margin-137.8547-232.7524-381.314-1397.927-182.5452-113.3309
Net Profit Margin-124.7471-232.752447.5713-1125.839-176.5334-112.0181
Asset Turnover0.60710.34180.12530.10870.2630.3804
Inventory Turnover Ratio3.2466.28244.873527.04340.83320.9222
Receiveable Turnover4.61754.4196.846332.52444.29023.0159
Days Sales In Receivables79.047382.598553.313211.222385.0772121.0241
ROE - Return On Equity-377.4533-176.5737-39.7294-237.0981-66.9356-54.0282
Return On Tangible Equity-602.2367-213.4242-42.9096-274.6266-141.3521-73.5573
ROA - Return On Assets-83.6916-79.5463-27.8547-130.5178-46.4259-42.6061
ROI - Return On Investment-377.4532-108.0609-33.3378-173.8836-66.9356-54.0282
Book Value Per Share3.662918.670953.17834.9353--
Operating Cash Flow Per Share17.4733-4.7177-1.7828.2488-33.7577-
Free Cash Flow Per Share18.0284-4.405-0.9647.5677-34.8149-